Pulling Back the Curtain on Clinical Trials & Diverse Patient Populations
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Valerie Callender, professor of dermatology at Howard University School of Medicine. Dr. Callender explains why patients from diverse populations may be hesitant to participate in clinical trials. She shares ways researchers can overcome barriers to recruitment, and why representation among the research team matters. Ac …
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Valerie Callender, professor of dermatology at Howard University School of Medicine. Dr. Callender explains why patients from diverse populations may be hesitant to participate in clinical trials. She shares ways researchers can overcome barriers to recruitment, and why representation among the research team matters. Ac … Continue reading "Pulling Back the Curtain on Clinical Trials & Diverse Patient Populations"
INTRODUCTION
As the United States population becomes increasingly diverse, it is exceedingly important for dermatologists to be knowledgeable about treating patients with skin of color (SOC). The published literature is an especially valuable resource for treating SOC. Many prevalent dermatological conditions, such as acne vulgaris, atopic dermatitis, and psoriasis, differ histologically and/ … 
The following is a summary of one of the many Q&A sessions held during the 2020 Skin of Color Virtual Update. During this particular session, questions were moderated by SOCU Co-Chair Dr. Andrew Alexis and answered by Drs. Ginette Okoye and Candrice Heath. The audience posed important questions and the faculty offered insightful answers regarding atopic dermatitis, hidradenitis suppurativa, h … 
I still treat my acne twice daily with a whole cabinet full of various topicals. I’ve tried and failed doxycycline because it disrupts every single molecule of bacterial flora in my body. I’ve tried and failed spironolactone because I was the poster child for nearly all of its annoying and inconvenient side effects. I’ve tried and failed several OCPs because my body was a little too convince … 
Morbihan Disease (MD) is a rare condition but can be a very rewarding diagnosis to make. I interviewed Dr. Kimberly Huerth on her poster presentation of an African-American man with long-standing, progressive Morbihan Disease that took 16 years to diagnose. MD in patients of skin of color may be underreported as well as underdiagnosed. Similarly, rosacea in skin of color is often overlooked and th … 